Finance

Lists
COHANCE:NSE
Cohance Lifesciences Ltd
456,50 INR
-1,63%
(-7,55) 1D
19-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for COHANCE...
Open
468,00 INR
High
468,00 INR
Low
456,00 INR
Mkt. cap
174,66 млд
Avg. vol.
1,10 млн
Volume
354,46 миң
P/E ratio
164,85
52-wk high
917,85 INR
52-wk low
266,70 INR
EPS
2,77 INR
No. of employees
3 миң
Open
468,00 INR
High
468,00 INR
Low
456,00 INR
Mkt. cap
174,66 млд
Avg. vol.
1,10 млн
Volume
354,46 миң
P/E ratio
164,85
52-wk high
917,85 INR
52-wk low
266,70 INR
EPS
2,77 INR
No. of employees
3 миң
News stories
From web sources and news partners
About Cohance Lifesciences Ltd
CEO-
Employees2,81 миң
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitecohance.com
Last report
2026-ж., 5-авг.
Fiscal period
Q1 2027
-0,63 INR / 1,00 INR
-163,00%miss
Revenue / Est. (INR)
4,22 млд / 5,00 млд
-15,61%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,56 млд
5,45 млд
6,19 млд
4,22 млд
Cost of goods sold
1,41 млд
1,59 млд
3,56 млд
1,20 млд
Cost of revenue
1,41 млд
1,59 млд
3,56 млд
1,20 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,27 млд
1,19 млд
1,47 млд
1,33 млд
Operating expense
3,38 млд
3,37 млд
2,14 млд
3,50 млд
Total operating expenses
4,79 млд
4,96 млд
5,70 млд
4,71 млд
Operating income
769,30 млн
484,10 млн
491,10 млн
-483,80 млн
Other non operating income
156,00 млн
61,60 млн
-310,30 млн
122,50 млн
EBT including unusual items
837,70 млн
406,00 млн
199,10 млн
-428,70 млн
EBT excluding unusual items
837,70 млн
454,60 млн
171,40 млн
-428,70 млн
Income tax expense
173,80 млн
115,80 млн
116,00 млн
23,20 млн
Effective tax rate
20,75%
28,52%
58,26%
-5,41%
Other operating expenses
1,67 млд
1,72 млд
152,80 млн
1,68 млд
Net income
740,80 млн
367,20 млн
195,50 млн
-241,20 млн
Net profit margin
13,33%
6,74%
3,16%
-5,71%
Earnings per share
1,93
0,55
0,68
-0,63
Interest and investment income
-
-
27,30 млн
-
Interest expense
-87,60 млн
-91,10 млн
-91,90 млн
-67,40 млн
Net interest expenses
-87,60 млн
-91,10 млн
-64,60 млн
-67,40 млн
Depreciation and amortization charges
440,20 млн
469,40 млн
512,30 млн
495,40 млн
EBITDA
1,23 млд
677,82 млн
865,38 млн
-15,48 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору